Interventions for Nongenital Molluscum Contagiosum in Persons Without Immune Deficiency.
Level III
Where this comes from
- Record sourced from PubMed, PMID 29282454.
- Also identified by DOI 10.1001/jamadermatol.2017.5118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
How effective and safe are treatments for nongenital molluscum contagiosum in persons without immune deficiency? Compared with placebo, imiquimod, 5%, cream was not more effective in clearing molluscum contagiosum and caused more local adverse effects, including application site reactions, in children aged 2 to 12 years; because high-quality evidence for other interventions is lacking, allowing for natural resolution of the infection remains a reasonable approach.
Medical subject headings
- Imiquimod
- Immunocompetence
- Molluscum Contagiosum